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The human cytomegalovirus (hCMV) encodes the G pro-
tein-coupled receptor (vGPCR) US28. This receptor sig-
nals constitutively and interacts with a broad range of
chemokines, which are crucial to the pathophysiological
significance and immunoregulatory aspects of this recep-
tor. Chemokines and their receptors have been shown to
be key determinants of tumor growth and formation of
metastases. US28 exerts anti-tumorigenic effects in two
melanoma cell lines. Here we show that in contrast to all
other previously studied cell lines, US28 is expressed on
the cell surface in the melanoma cell lines Sbcl2 and
451Lu. We found that GASP – the G protein-coupled
receptor-associated sorting protein – which sorts US28
and many other GPCRs to the lysosomes is absent in
melanoma cells. The absence of GASP might affect the
tumor-suppressing properties of US28. Melanoma cells
produce several chemokines, one of them is the monocyte
chemoattractant protein-1 (MCP-1). We found that the
MCP-1 level in the supernatants of 451Lu cells increased
when US28 wt was expressed. US28Δ317, a truncated
mutant of US28 which is known to have enhanced signal-
ling capacity compared to US28 wt, increased the MCP-1
concentration up to 20-fold. We speculate that the consti-
tutive signalling of the receptor regulates the MCP-1 pro-
duction of melanoma cells.
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